Ayala Pharmaceuticals Inc (ADXS)

[equaloppforall]

Fbg, while the number sounds good at face value, $1 billion in overall milestone payments for US and Europe rights seems somewhat lowball for AXAL, unless you are taking only about Cervical (not H & N and Anal), and the revenue sharing even for just cervical is at least 50-50.

I mean ADXS has already done all the hard work and has reached Phase 3 in the US with SPA and Fast Track and is poised to succeed on its own, all at current shareholder expense. AXAL is our most advanced product and is ahead of something like NEO by at least 3-4 years in clinical development. And NEO itself has a 500 million deal. So for someone like AZN, or anyone else, to simply swoop in and take all of AXAL for US and Europe rights for just 1 billion would mean we have made a mediocre deal at best.

But I would love to see a deal though and like the talk of billions, instead of millions :-